A method for treating a neurodegenerative condition, in an animal of the mammalian species, including humans, comprising the step of administering to ganglion cells and their axons (optic nerve) of said mammal a pharmaceutical composition which comprises as its active ingredient one or more compounds having activity for blocking a reverse mode of the sodium/calcium exchanger.

 
Web www.patentalert.com

< USE OF FORMS OF PROPOFOL FOR TREATING DISEASES ASSOCIATED WITH OXIDATIVE STRESS

> IL-17A/F heterologous polypeptides and therapeutic uses thereof

~ 00446